Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: tlhutch who wrote (141789)	2/2/2005 2:22:03 PM
From: M0NEYMADE	Read Replies (2) \| Respond to of 150070

,,,,,,,Nice --MoneyMade

To: tlhutch who wrote (141789)	2/10/2005 10:12:42 AM
From: tlhutch	Respond to of 150070

HEE Corp. to Roll out HPB-84, a Nutraceutical Shown to Be Safe and Effective Wednesday February 9, 4:59 pm ET HUTCHINSON, Kan.--(BUSINESS WIRE)--Feb. 9, 2005--HEE Corporation, Inc. (HCCF on OTC Pink Sheets), the international manufacturer of HPB-84, a new nutraceutical that was developed in India is shown to be safe and effective. ADVERTISEMENT The version of HPB-84, purchased by HEE, was originally developed by Indian scientists to help address some of the multiple factors of Type II Diabetes. Before that, the original formula had been in use for over 200 years in India. The current formula has been successfully administered in India for ten years. After HEE Corp purchased the rights to the product, they added enhancements to it and created the version of HPB-84 which is now becoming available for administration. The effectiveness has been startling, not only for the symptoms of Type II Diabetes, but it has the added benefit of dramatically reducing weight. Patients taking the tablets find they can live a normal life, eating what they want and yet keeping themselves on normal glucose level while taking HPB-84, which HEE Corp has the exclusive world-wide rights. For those taking medications, the product caused no adverse interaction with medication and resulted in improvements in their well being and lifestyles. "After reviewing all data and asking all the questions at hand, I am confident that the full distribution roll out of our signature product, HPB-84, should begin at once," commented Herbert Becker, HEE Corp CEO and Chairman of the board. He went on to say, "We have identified a main distribution source which will assure us of a secure and qualified route for HPB-84." About HEE Founded in 2004, HEE ("HCCF.PK") is the worldwide leader providing a corporate vehicle for a new and extremely promising nutraceutical for Type II Diabetes. This nutraceutical was developed in India. HEE will begin to distribute its product through its distribution network. HEE's headquarters is based in Hutchinson, Kansas. Forward-Looking Statements: Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially because of factors such as: entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, changes in licensing programs, product price discounts, delays in product development and related product release schedules, sales channel disruption such as the bankruptcy of a major distributor, and reliance on sole source suppliers for key components that could result in delays in product delivery, any of which may cause revenues and income to fall short of anticipated levels; technological shifts; the ability to have access to distribution channels that are controlled by third parties; the risk of unanticipated increased costs; the continued ability to protect the company's intellectual property rights; adverse effects on our business that might result if an unauthorized disclosure of a significant portion of our formula were to occur; the ability to obtain on acceptable terms the right to incorporate in the company's products and services; changes in product and service mix; maturing product life cycles; product sale terms and conditions; the risk that actual or perceived vulnerabilities in our products could adversely affect our revenues; implementation of operating cost structures that align with revenue growth; unavailability of insurance; uninsured losses; adverse results in litigation; unanticipated tax liabilities; the effects of terrorist activity and armed conflict such as disruptions in general economic activity and changes in our operations and security arrangements; the effects of a major earthquake, cyber-attack or other catastrophic event that results in the destruction or disruption of any of our critical business or information technology systems; the level of corporate information technology spending and changes in general economic conditions that affect demand; currency fluctuations; and financial market volatility or other changes affecting the value of our investments that may result in a reduction in carrying value and recognition of losses including impairment charges. All information in this release is as of February 9, 2005 is accurate. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations. HEE is either registered trademarks or trademarks of HEE Corp., in the United States and/or other countries. The names of actual companies or products mentioned herein may be the trademarks of their respective owners. For more information, financial analysts and investors only: Darci Brooks, Investor Relations (620) 663-3333 Note to editors: If you are interested in viewing additional information on HEE Corp, please visit the HEE Corp web page at hee-corp.com on HEE Corps information pages. Web links, telephone numbers and titles were correct at time of publication, but may since have changed. Shareholder and financial information is available at hee-corp.com -------------------------------------------------------------------------------- Contact: HEE Corporation, Inc. Financial Analysts and Investors Only: Darci Brooks, 620-663-3333 -------------------------------------------------------------------------------- Source: HEE Corporation, Inc.